Innova Captab
INNOVACAP · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 29, 2023

Stock Price vs Company Growth
1d
0.3%
1w
8.1%
1m
14.2%
3m
13.5%
6m
21.7%
1y
87.5%
all
47.0%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec22Jun23Dec23Jun24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

899 0.3%
664
1,098
Company Overview

Sales
1,192 Cr
Growth: 14.1%
Profit after Tax
127 Cr
Growth: 7.7%
Small Cap
5,144 Cr
P/E: 39.9x
Industry P/E: 30.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 1,192
Growth 14.1%
EBITDA 14.8%
P/S 4.3x
Dividend 0.0%
P/E 39.9x
Book Value ₹ 162
PEG Ratio 2.9x
ROE 14.5%
P/B 5.5x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Its business includes (i) a CDMO business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business and (iii) an international branded generics business.Products of the companyTabletsCapsules Dry syrups Dry powder injection.
Followers (1)